Sarcopenia assessment by new EWGSOP2 criteria for predicting chemotherapy dose-limiting toxicity in patients with gastrointestinal tract tumors.

Emir CelikVeysel SuzanNilay Sengul SamanciAysegul Akkan SuzanMehmet KaradagSerdar SahinMuhammed Samil AslanHakan YavuzerNebi Serkan DemirciAlper DoventasFuat Hulusi Demirelli

Published in: European geriatric medicine (2021)

Assessment of sarcopenia evaluated with the current EWGSOP2 diagnostic criteria is useful in predicting chemotherapy DLT development in patients with a diagnosis of GI cancer. In the future, current EWGSOP2 recommendations should be considered while designing a study investigating the correlation between sarcopenia and chemotoxicity.

Keyphrases

skeletal muscle
locally advanced
community dwelling
papillary thyroid
oxidative stress
current status
clinical practice
squamous cell
childhood cancer
oxide nanoparticles